International Assets Investment Management, LLC Lantern Pharma Inc. Transaction History

International Assets Investment Management, LLC

  • $36.5 Billion
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Jul 14, 2021
SELL
$12.94 - $19.89 $11,646 - $17,901
-900 Closed
0 $0
Q4 2020

Jan 22, 2021
BUY
$15.1 - $20.69 $13,590 - $18,621
900 New
900 $17.3 Million

Others Institutions Holding LTRN

# of Institutions
34
Shares Held
1.31M
Call Options Held
39.8K
Put Options Held
6.1K
View Full List

About Lantern Pharma Inc.

LTRN Quotes by TradingView
  • Ticker LTRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 10,830,900
  • Market Cap $37M
  • Description
  • Lantern Pharma Inc., a clinical stage biotechnology company, focuses on artificial intelligence, machine learning, and genomic data to streamline the drug development process. Its advanced drug candidate is LP-100, which is in phase II clinical trials to treat metastatic, castration-resistant, and prostate cancer. The company also develops LP-30...
More about LTRN
Track This Portfolio

Track International Assets Investment Management, LLC Portfolio

Follow International Assets Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of International Assets Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on International Assets Investment Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email